127 related articles for article (PubMed ID: 15802801)
21. Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo.
von Moltke LL; Greenblatt DJ; Duan SX; Daily JP; Harmatz JS; Shader RI
J Pharm Sci; 1998 Oct; 87(10):1184-9. PubMed ID: 9758674
[TBL] [Abstract][Full Text] [Related]
22. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
23. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
24. Effect of psychotropic drugs on the 21-hydroxylation of neurosteroids, progesterone and allopregnanolone, catalyzed by rat CYP2D4 and human CYP2D6 in the brain.
Niwa T; Okada K; Hiroi T; Imaoka S; Narimatsu S; Funae Y
Biol Pharm Bull; 2008 Mar; 31(3):348-51. PubMed ID: 18310890
[TBL] [Abstract][Full Text] [Related]
25. Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver.
Wójcikowski J; Haduch A; Daniel WA
Pharmacol Rep; 2013; 65(5):1247-55. PubMed ID: 24399720
[TBL] [Abstract][Full Text] [Related]
26. Mechanism-based inhibition of CYP activities in rat liver by fluoxetine and structurally similar alkylamines.
Murray M; Murray K
Xenobiotica; 2003 Oct; 33(10):973-87. PubMed ID: 14555335
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
von Bahr C; Spina E; Birgersson C; Ericsson O; Göransson M; Henthorn T; Sjöqvist F
Biochem Pharmacol; 1985 Jul; 34(14):2501-5. PubMed ID: 4015690
[TBL] [Abstract][Full Text] [Related]
28. Rat CYP2D2, not 2D1, is functionally conserved with human CYP2D6 in endogenous morphine formation.
Grobe N; Kutchan TM; Zenk MH
FEBS Lett; 2012 Jun; 586(13):1749-53. PubMed ID: 22641033
[TBL] [Abstract][Full Text] [Related]
29. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
30. Different regiospecificity in the hydroxylation of the antidepressant desmethylimipramine between rat brain and liver.
Hansson T; von Bahr C; Marklund M; Svensson JO; Ingelman-Sundberg M; Lundström J
Pharmacol Toxicol; 1992 Dec; 71(6):416-9. PubMed ID: 1480550
[TBL] [Abstract][Full Text] [Related]
31. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.
Bromek E; Haduch A; Daniel WA
Eur J Pharmacol; 2010 Jan; 626(2-3):171-8. PubMed ID: 19818757
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2.
Yamamoto Y; Tasaki T; Nakamura A; Iwata H; Kazusaka A; Gonzalez FJ; Fujita S
Pharmacogenetics; 1998 Feb; 8(1):73-82. PubMed ID: 9511184
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of H1-antihistamines on CYP2D6- and CYP2C9-mediated drug metabolic reactions in human liver microsomes.
He N; Zhang WQ; Shockley D; Edeki T
Eur J Clin Pharmacol; 2002 Feb; 57(12):847-51. PubMed ID: 11936702
[TBL] [Abstract][Full Text] [Related]
34. 1-Ethynylpyrene, a suicide inhibitor of cytochrome P-450 dependent benzo[a]pyrene hydroxylase activity in liver microsomes.
Gan LS; Acebo AL; Alworth WL
Biochemistry; 1984 Aug; 23(17):3827-36. PubMed ID: 6487578
[TBL] [Abstract][Full Text] [Related]
35. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
Butler AM; Murray M
Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222
[TBL] [Abstract][Full Text] [Related]
36. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.
Haduch A; Bromek E; Daniel WA
Eur J Pharmacol; 2011 Jan; 651(1-3):51-8. PubMed ID: 21115002
[TBL] [Abstract][Full Text] [Related]
37. Mechanism-based inactivation of CYP2C11 by diclofenac.
Masubuchi Y; Ose A; Horie T
Drug Metab Dispos; 2001 Sep; 29(9):1190-5. PubMed ID: 11502726
[TBL] [Abstract][Full Text] [Related]
38. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
39. Contribution of flavin-containing monooxygenase and cytochrome P450 to imipramine N-oxidation in rat hepatic microsomes.
Narimatsu S; Yamamoto S; Kato R; Masubuchi Y; Horie T
Biol Pharm Bull; 1999 Jun; 22(6):567-71. PubMed ID: 10408227
[TBL] [Abstract][Full Text] [Related]
40. Mechanism-based inactivation of human cytochrome P4502C8 by drugs in vitro.
Polasek TM; Elliot DJ; Lewis BC; Miners JO
J Pharmacol Exp Ther; 2004 Dec; 311(3):996-1007. PubMed ID: 15304522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
